In the last 12 months, insiders at Ocugen, Inc. ($OCGN) filed 35 transactions with the SEC: 2 open-market purchases totaling $31,943 and 0 sales totaling $0. Net insider sentiment: net buying.
Ocugen, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Musunuri Shankar (Chief Executive Officer) — 6 transactions totaling $276,130
- Zhang Junge (Director) — 8 transactions totaling $154,303
- Upadhyay Arun (See Remarks) — 6 transactions totaling $66,714
- Castillo Kirsten (Director) — 3 transactions totaling $22,848
- Fernandes Prabhavathi (Director) — 2 transactions totaling $9,095
View all SEC Filings for Ocugen, Inc. (OCGN).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Zhang Junge | Director | M | Common Stock | 112205 | $0.46 | 1,292,387.0000 | 304,003,247 | 9.51% | 0.04% |
| April 1, 2026 | Zhang Junge | Director | M | Option (right to buy) | 112205 | $0.00 | 0.0000 | 304,003,247 | 100.00% | 0.04% |
| April 1, 2026 | Zhang Junge | Director | M | Option (right to buy) | 15000 | $0.00 | 0.0000 | 304,003,247 | 100.00% | 0.00% |
| April 1, 2026 | Zhang Junge | Director | M | Common Stock | 66929 | $1.42 | 1,359,316.0000 | 304,003,247 | 5.18% | 0.02% |
| April 1, 2026 | Zhang Junge | Director | M | Common Stock | 15000 | $0.51 | 1,180,182.0000 | 304,003,247 | 1.29% | 0.00% |
| April 1, 2026 | Zhang Junge | Director | M | Option (right to buy) | 66929 | $0.00 | 0.0000 | 304,003,247 | 100.00% | 0.02% |
| Jan. 2, 2026 | Ramachandran Ramesh | Chief Accounting Officer | A | Option (Right to Buy) | 310950 | $0.00 | 310,950.0000 | 304,003,247 | 9999.99% | 0.10% |
| Jan. 2, 2026 | Ramachandran Ramesh | Chief Accounting Officer | A | Common Stock | 207300 | $0.00 | 209,100.0000 | 304,003,247 | 9999.99% | 0.07% |
| Jan. 2, 2026 | Musunuri Shankar | Chief Executive Officer | A | Option (Right to Buy) | 3123201 | $0.00 | 3,123,201.0000 | 304,003,247 | 9999.99% | 1.03% |
| Jan. 2, 2026 | Musunuri Shankar | Chief Executive Officer | A | Common Stock | 3123201 | $0.00 | 6,101,223.0000 | 304,003,247 | 104.88% | 1.03% |
| June 5, 2025 | Chandrasekhar Satishchandran | Director | A | Option (Right to Buy) | 151316 | $0.00 | 151,316.0000 | 270,995,121 | 9999.99% | 0.06% |
| June 5, 2025 | Coleman Blaise | Director | A | Option (Right to Buy) | 151316 | $0.00 | 151,316.0000 | 270,995,121 | 9999.99% | 0.06% |
| June 5, 2025 | Castillo Kirsten | Director | A | Option (Right to Buy) | 151316 | $0.00 | 151,316.0000 | 270,995,121 | 9999.99% | 0.06% |
| June 5, 2025 | Kompella Uday | Director | A | Option (Right to Buy) | 151316 | $0.00 | 151,316.0000 | 270,995,121 | 9999.99% | 0.06% |
| June 5, 2025 | Zhang Junge | Director | A | Option (Right to Buy) | 151316 | $0.00 | 151,316.0000 | 270,995,121 | 9999.99% | 0.06% |
| Jan. 2, 2025 | Musunuri Shankar | Chief Executive Officer | A | Option (Right to Buy) | 1827485 | $0.00 | 1,827,485.0000 | 270,995,121 | 9999.99% | 0.67% |
| Jan. 2, 2025 | Ramachandran Ramesh | Chief Accounting Officer | A | Option (Right to Buy) | 350146 | $0.00 | 350,146.0000 | 270,995,121 | 9999.99% | 0.13% |
| Jan. 3, 2025 | Upadhyay Arun | See Remarks | F | Common Stock | 41633 | $0.89 | 306,197.0000 | 270,995,121 | 11.97% | 0.02% |
| Jan. 2, 2025 | Upadhyay Arun | See Remarks | A | Option (Right to Buy) | 730994 | $0.00 | 730,994.0000 | 270,995,121 | 9999.99% | 0.27% |
| Jan. 3, 2025 | Musunuri Shankar | Chief Executive Officer | F | Common Stock | 177146 | $0.89 | 2,978,022.0000 | 270,995,121 | 5.61% | 0.07% |
| Jan. 2, 2025 | Qamar Huma | Chief Medical Officer | A | Option (Right to Buy) | 1145468 | $0.00 | 1,145,468.0000 | 270,995,121 | 9999.99% | 0.42% |
| Nov. 26, 2024 | Fernandes Prabhavathi | Director | P | Common Stock | 10000 | $0.91 | 10,000.0000 | 278,171,593 | 9999.99% | 0.00% |
| Nov. 22, 2024 | Castillo Kirsten | Director | P | Common Stock | 25000 | $0.91 | 75,000.0000 | 278,171,593 | 50.00% | 0.01% |
| Sept. 16, 2024 | Upadhyay Arun | See Remarks | F | Common Stock | 842 | $1.17 | 347,830.0000 | 257,353,857,000 | 0.24% | 0.00% |
| June 28, 2024 | WHITTINGTON MARNA C | Director | A | Option (Right to Buy) | 66929 | $0.00 | 66,929.0000 | 257,232,636,000 | 9999.99% | 0.00% |
| June 28, 2024 | Castillo Kirsten | Director | A | Option (Right to Buy) | 66929 | $0.00 | 66,929.0000 | 257,232,636,000 | 9999.99% | 0.00% |
| June 28, 2024 | Zhang Junge | Director | A | Option (Right to Buy) | 66929 | $0.00 | 66,929.0000 | 257,232,636,000 | 9999.99% | 0.00% |
| June 28, 2024 | Fernandes Prabhavathi | Director | A | Option (Right to Buy) | 66929 | $0.00 | 66,929.0000 | 257,232,636,000 | 9999.99% | 0.00% |
| June 17, 2024 | Upadhyay Arun | See Remarks | F | Common Stock | 917 | $1.42 | 348,672.0000 | 257,232,636,000 | 0.26% | 0.00% |
| June 28, 2024 | Kompella Uday | Director | A | Option (Right to Buy) | 66929 | $0.00 | 66,929.0000 | 257,232,636,000 | 9999.99% | 0.00% |
| April 16, 2024 | Qamar Huma | Chief Medical Officer | A | Option (Right to Buy) | 308465 | $0.00 | 308,465.0000 | 257,232,636,000 | 9999.99% | 0.00% |
| Jan. 3, 2024 | Upadhyay Arun | See Remarks | F | Common Stock | 41633 | $0.65 | 349,589.0000 | 244,327,057 | 10.64% | 0.02% |
| Jan. 3, 2024 | Musunuri Shankar | Chief Executive Officer | F | Common Stock | 180204 | $0.65 | 3,155,168.0000 | 244,327,057 | 5.40% | 0.07% |
| Jan. 2, 2024 | Upadhyay Arun | See Remarks | A | Option (Right to Buy) | 137795 | $0.00 | 137,795.0000 | 244,327,057 | 9999.99% | 0.06% |
| Jan. 2, 2024 | Musunuri Shankar | Chief Executive Officer | A | Option (Right to Buy) | 492126 | $0.00 | 492,126.0000 | 244,327,057 | 9999.99% | 0.20% |